SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients
Clinical trial NCT04521309 · COMPLETED
Trial details
- NCT number
- NCT04521309
- Sponsor
- Dow University of Health Sciences
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-19
- Primary completion
- 2021-01-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.